GLP1R and urinary tract infection: For urinary tract infection (UTI) outcomes, 475 patients in the BTX-A-only cohort and 504 in the BTX-A + GLP-1 RA cohort were excluded due to a documented history of UTI prior to receiving BTX-A or BTX-A + GLP-1 RA in each group, respectively.